Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$108.81 - $179.33 $108 - $179
-1 Reduced 20.0%
4 $1,000
Q1 2022

May 11, 2022

SELL
$119.61 - $157.85 $29,902 - $39,462
-250 Reduced 98.04%
5 $1,000
Q4 2021

Jan 10, 2022

SELL
$142.57 - $190.86 $88,108 - $117,951
-618 Reduced 70.79%
255 $39,000
Q3 2021

Nov 24, 2021

BUY
$142.45 - $169.82 $427 - $509
3 Added 0.34%
873 $148,000
Q4 2020

Jan 15, 2021

BUY
$164.63 - $211.93 $143,228 - $184,379
870 New
870 $152,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.